Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;54(5):735-741.
doi: 10.1111/imj.16325. Epub 2024 Jan 11.

Patients' perception of the benefits of palliative systemic therapy for advanced cancer

Shalini Subramaniam  1   2   3   4 , Diana H Adams  5   6 , Annette Tognela  5   6 , Felicia Roncolato  1   5 , Po Y Yip  5   6 , Stephanie H-S Lim  5   6 , Aflah Roohullah  5   6   7 , Martin R Stockler  1   3   4   8 , Belinda Kiely  1   3   4   5
Affiliations

Patients' perception of the benefits of palliative systemic therapy for advanced cancer

Shalini Subramaniam et al. Intern Med J. 2024 May.

Abstract

Background: Patients with advanced cancer who misunderstand their prognosis and chance of cure tend to overestimate the likely benefits of palliative systemic therapy.

Aim: To determine patient perceptions of palliative systemic therapy benefits in advanced cancer.

Methods: We surveyed 104 outpatients with advanced cancer receiving systemic anticancer therapy and their treating oncologists. Patients recorded their understanding of treatment impact on chance of cure and symptoms. Life expectancy was estimated by patients and oncologists. A visual analogue scale (0-10) was used to record how patients and oncologists valued quality of life (QOL) and length of life (LOL) (<4 QOL most important; 4-7 QOL and LOL equal; >7 LOL most important). Patient-oncologist discordance was defined as a ≥4-point difference.

Results: The main reasons patients selected for receiving treatment were to live longer (54%) and cure their cancer (36%). Most patients reported treatment was very/somewhat likely to prolong life (84%) and improve symptoms (76%), whereas 20% reported treatment was very/somewhat likely to cure their cancer. 42% of patients selected a timeframe for life expectancy (choice of four timeframes between <1 year and ≥5 years); of these, 62% selected a longer timeframe than their oncologist. When making treatment decisions, 71% of patients (52% of oncologists) valued QOL and LOL equally. Patient-oncologist discordance was 21%, mostly because of oncologists valuing QOL more than their patients (70%).

Conclusion: At least 20% of patients receiving systemic therapy for advanced cancer reported an expectation of cure. Most patients and oncologists value QOL and LOL equally when making treatment decisions.

Keywords: communication; incurable cancer; prognosis; survey; survival time.

PubMed Disclaimer

References

    1. Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL et al. Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med 2012; 367: 1616–1625.
    1. Liu PH, Landrum MB, Weeks JC, Huskamp HA, Kahn KL, He Y et al. Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers. J Palliat Med 2014; 17: 673–682.
    1. Tattersall MHN. Gaps in patients’ understanding of palliative chemotherapy. Can we better communicate that treatment is not curative? Expert Rev Qual Life Cancer Care 2017; 2: 245–249.
    1. Bergerot CD, Bergerot PG, Philip EJ, Hsu JA, Dizman N, Vaishampayan U et al. Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy. J Immunother Cancer 2019; 7: 71.
    1. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 1998; 279: 1709–1714.

LinkOut - more resources